The Asian Pacific Association for the Study of the Liver [APASL]

Hepatology International Online Free Subscription is available for all APASL members through the login page!

Call for Abstracts of APASL-ONCOLOGY 2026 TOKYO!

Call for Abstracts of APASL-ONCOLOGY 2026 TOKYO!

APASL-ONCOLOGY 2026 TOKYO Abstract submission deadline has been extended until January 20, 2026 !  https://www.apasl.info/wp-apasl/wp-content/uploads/2026/01/f1d9ce63a105a76047a73f8c42cbbb96.mp4 Dear Colleagues, A Happy New Year! I hope this message finds you well, and I would like to extend my sincere best wishes to you for a successful and fulfilling year ahead. First of all, I would like to express my deepest appreciation for your continued dedication to APASL and its scientific activities. It is grateful to announce you the APASL-ONCOLOGY 2026 TOKYO will be held on April 2–3, 2026, at the University of Tokyo. And now we are calling for free papers. While we have received a strong number of abstracts to date, further … [Read more]

APASL 2026 Istanbul / Regarding Your Participation in Artificial Intelligence Studies

APASL 2026 Istanbul / Regarding Your Participation in Artificial Intelligence Studies

Subject: APASL 2026 Istanbul / Regarding Your Participation in Artificial Intelligence Studies AI BASED STU0DY LİNK https://forms.gle/4zvddwNak8J6ckeJ8   On behalf of the Organizing Committee of the 35th APASL Congress (APASL 2026 Istanbul), which will be held in Istanbul on 22–25 April 2026, we are honored to invite you to participate in four studies on Artificial Intelligence (AI) that will be conducted and subsequently presented at the congress.   Study 1 Topic: Can we predict the development of hepatocellular carcinoma (HCC) in the course of chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma using artificial intelligence? Can an AI-mediated scoring system be developed to predict HCC development in these diseases? Study 2 … [Read more]

APASL STC 2026 Almaty will be held on October 8-9, 2026 !!

APASL STC 2026 Almaty will be held on October 8-9, 2026 !!

With the theme of ” Liver Diseases and Pregnancy “, APASL STC 2026 Almaty will be held on October 8-9, 2026 !! We are thrilled to welcome you all to the beautiful city of Almaty !! Please wait for the detailed information about abstract submission and registration !!

Call for Abstracts !! APASL Oncology 2026 Tokyo !!

Call for Abstracts !! APASL Oncology 2026 Tokyo !!

CALL FOR ABSTRACTS – APASL-ONCOLOGY 2026 TOKYO https://www.apasl-oncology2026tokyo.org/ 📅 April 2–3, 2026 | University of Tokyo Abstract submission is now OPEN!We invite clinical, surgical, interventional, oncology, and basic research abstracts. ✨ Young Investigator Award: 20 Awards– Age ≤40– Must complete Early Bird Submitted by Dec 25, 2025(Christmas Day !)– First author & presenter required 🎥 Video Session Open!TACE / TARE / HAIC / RFA / MWA / EUS-BD / ERCP / Surgery / Transplantation 🗓 Deadline: Dec 31, 2025(Short extension may be considered) Join us in Tokyo and shape the future of liver cancer care!

APASL STC 2025 Yangon was held with a BIG SUCCESS !!

APASL STC 2025 Yangon was held with a BIG SUCCESS !!

APASL STC 2025 Yangon was held successfully !! We greatly appreciate your enthusiasm and devotion to bring about this success to the conference !! We hope you had a fulfilling and exciting time at the conference !!

Invitation to APASL Hepatology Webinar

Invitation to APASL Hepatology Webinar

Highlight of  “Hepatology International” Episode 9-4   Viral Hepatitis Friday,  December 19, 2025 at 17:00 (UTC/GMT +08:00) Asia/Beijing Time It is our great pleasure to invite you to participate in the Asian Pacific Association for the Study of Liver (APASL) Hepatology Webinar Episode 9. APASL Hepatology Webinar ” Highlight of Hepatology International ” with the theme of Viral Hepatitis is scheduled on December 19 at 17:00-18:00 ( Beijing Time)!! We look forward to your participation !! Please don’t miss it! Please simply join the webinar through following Invitation Link! https://us02web.zoom.us/j/87905003230?pwd=sCTZXhZDdFsbuNnfw2oj8pS60Bhcir.1 Passcode: apasl ID: 879 0500 3230

Invitation for application of APASL Awards !!

Invitation for application of APASL Awards !!

Dear, APASL members   It is a great pleasure to announce you that APASL will call for application of the APASL Named Award and Rising Star Award which will be included in the scientific program of the next APASL Annual Meeting. Following is the information regarding the application for the Awards. We are looking forward your application.   Named Awards 1) APASL Okuda-Omata Distinguished Award 2) APASL Powell-Sarin Achievement Award 3) APASL Lesmana-Sollano Great Mentor Award   APASL will offer USD 5,000 for each. <Selection Criteria for Named Awards> Presenters will be selected based upon the following criteria High original scientific research and achievements in a given area of liver … [Read more]

Please check out the details about AWARD !! APASL Oncology 2026 Tokyo !!

Please check out the details about AWARD !! APASL Oncology 2026 Tokyo !!

Those abstracts submitted by December 25, 2025 are subject to Young Investigator Award !! We are waiting for a lot of applications !! 🏆 Awards To encourage and recognize excellence, the following awards will be presented during the congress: Presidential Awards – For the most outstanding abstracts across all categories. Young Investigator Awards (20 awards) – For researchers under 40 years old, who will attend and present their work in person. These will be selected from abstracts submitted by December 25, 2025, to encourage early and high-quality submissions. Best Video Award – For the most creative and technically outstanding video submission. All awardees will be honored during the Closing Ceremony … [Read more]

Get ready for next year’s STC !!

Get ready for next year’s STC !!

Please check out the information about APASL STC 2026 Almaty !! With the theme of Liver Diseases and Pregnancy, APASL STC 2026 Almaty will be held on October 8-9, 2026 !! We are waiting for your participation !! https://qasl.kz/

On-demand Streaming is available !! APSAL STC 2025 Tokyo

On-demand Streaming is available !! APSAL STC 2025 Tokyo

On-demand Streaming is available! (Digest version of highlight programs) APASL STC 2025 Tokyo offer on-demand streaming from December 2025 for two months. You can watch the highly informative “State-of-the-Art Lectures”, highlight talks by renowned researchers, Symposiums, Workshops, and Plenary Session. General price to watch: US$50 Please go to the Online Registration https://app.payvent.net/embedded_forms/show/690addf20da6f926908909fd *If you have already registered for APASL STC 2025 Tokyo, there is no additional charge. The information for On-demand Streaming will be sent by email. *APASL members can view the event for free. We will direct you to the member page. The information for On-demand Streaming will be sent by email. Enjoy the Video Streaming of APASL STC … [Read more]

APASL STC 2025 Qingdao was held with a BIG SUCCESS !!

APASL STC 2025 Qingdao was held with a BIG SUCCESS !!

Thanks to your great cooperation and contribution, APASL STC 2025 Qingdao was held successfully!! Please check out the photos and short video from the following and take a glimpse of the conference !!

Professor Masao Omata was awarded APDWF Meritorious Award at APDW 2025 Singapore !!

Professor Masao Omata was awarded APDWF Meritorious Award at APDW 2025 Singapore !!

Congratulations !! Professor Masao Omata was awarded APDWF Meritorious Award at APDW 2025 Singapore !! We would like to extend our heartfelt congratulations to Professor Omata for his great achievements and contributions for the development of Hepatology over the decades, and sincerely wish him ever-increasing success and prosperity! Professor George Lau respectfully read citation as below. https://www.apasl.info/wp-apasl/wp-content/uploads/2025/11/Masao-Omata_citation_20_11_2025-1.pdf

The B-Together study explores the potential of bepirovirsen in modulating immune responses to enhance the clearance of HBV-infected hepatocytes.

The B-Together study explores the potential of bepirovirsen in modulating immune responses to enhance the clearance of HBV-infected hepatocytes.

The B-Together study explores the potential of bepirovirsen in modulating immune responses to enhance the clearance of HBV-infected hepatocytes. This research highlights a promising step toward achieving a functional cure for chronic hepatitis B through targeted immunomodulation. Read the full article: https://link.springer.com/article/10.1007/s12072-025-10917-0 #HepatitisB#HBVResearch#Immunotherapy#Hepatology#LiverDisease#Bepirovirsen#HepatologyInternational#ViralHepatitis#ClinicalResearch#HealthcareProfessionals

This cross-sectional analysis emphasizes the importance of integrated care approaches in managing patients with MASLD and related comorbidities.

This cross-sectional analysis emphasizes the importance of integrated care approaches in managing patients with MASLD and related comorbidities.

Emerging data from the Paracelsus 10,000 Study reveal a significant association between depression and metabolic dysfunction-associated steatotic liver disease (MASLD), underscoring the complex interplay between mental health and metabolic liver disease. This cross-sectional analysis emphasizes the importance of integrated care approaches in managing patients with MASLD and related comorbidities. Read the full article: https://link.springer.com/article/10.1007/s12072-025-10922-3 #MASLD#LiverHealth#Depression#MentalHealth#Hepatology#MetabolicDisease#HepatologyInternational#LiverResearch#PublicHealth#HealthcareProfessionals

Do the therapeutic vaccines hold hope for the treatment of hepatitis B ?

Do the therapeutic vaccines hold hope for the treatment of hepatitis B ?

Emerging data from the Paracelsus 10,000 Study reveal a significant association between depression and metabolic dysfunction-associated steatotic liver disease (MASLD), underscoring the complex interplay between mental health and metabolic liver disease. This cross-sectional analysis emphasizes the importance of integrated care approaches in managing patients with MASLD and related comorbidities. Read the full article: https://link.springer.com/article/10.1007/s12072-025-10922-3 #MASLD#LiverHealth#Depression#MentalHealth#Hepatology#MetabolicDisease#HepatologyInternational#LiverResearch#PublicHealth#HealthcareProfessionals